2026-10-25
Martin Marietta Materials clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 28,437 +0.91%
S&P 7,689 +1.58%
GOLD $4,142 +1.70%
BTC $80,182 −0.28%
VIX 16.80 +1.14%
latest tape · as of 12:01 UTC
The Screen · Basic Materials · Building Materials
Martin Marietta Materials
MLM · a US exchange · USD · Market cap $38.4B · 9,600 employees
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally.
Not yet scored556.56 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 12:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price556.56 USD at the 4 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 4 Nov 2026
- Our regime readMarkup, as of 4 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.12)
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $406.55 to $467.53, base estimate $406.55 (screen dated 2026-11-04).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-09-25
- Options put/call open interest 1.12, read 2026-11-05
- Ethical screen not yet scored
Price556.56 USD
Fair value406.55
Ethical score87.4/100
Value readOvervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup540.41+3.0% to today ✓Accumulation gives way to Markup after a 10% rise in 7 days
2026-10-25Read Accumulation491.23+13.3% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-10-11Read Markdown490.77+13.4% to today Distribution gives way to Markdown after a 14% slide in 10 weeks
2026-08-05Read Distribution572.03-2.7% to today ✓Markdown gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
Martin Marietta Materials holds its Markup at $556.56. Consolidating, no directional conviction, held for 42 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 42 days |
| Price at the screen | $556.56 |
| Valuation | 35.14 trailing · 25.50 forward price to earnings |
| Values screen | Not scored · score 87.4 |
| Beta | 1.09 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 30.49% | Below 33% | Interest-bearing debt is just 30.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 4.18% | Below 49% | Money owed to the company is 4.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Martin Marietta Materials clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Martin Marietta Materials clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 4 Nov 2026: it trades above our $406.55 fair value estimate, narrow competitive moat, 21.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 36.9% above the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +14% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $406.55, with a range of $406.55 to $467.53, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsQuarries supply every boom, yet cycles erase gains
Picture every new highway or skyscraper relying on aggregates from a handful of quarries. Martin Marietta sits at the centre of that supply chain, posting 17 percent revenue growth and 40 percent margins, yet trades at 24.5 times forward earnings with a narrow moat and just 9 percent ROE. Fair value sits 20 percent below the current price, so the premium looks unwarranted.
We pass because the valuation already prices in perpetual strength in a business that rises and falls with construction spending. Analyst targets at 700 dollars ignore how quickly volumes can fall when interest rates stay high or public budgets tighten.
The real risk is the classic cyclical trap: high margins today mask peak earnings that compress sharply in the next downturn. Ethical screens clear, yet the numbers still show an expensive business in a volatile industry. Analysis, not advice.
| Forward P/E | 25.5xpriced for continued growth |
| Trailing P/E | 35.1xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 15.38 |
| EPS, forward | 21.19 |
| Revenue growth | +21.0%strong top-line growth |
| Profit margin | 36.7%highly profitable on every dollar of sales |
| Return on equity | 8.9%a modest return on shareholder capital |
| FCF yield | 1.55% |
| Dividend yield | 0.58% |
| Debt to equity | 0.55moderate, manageable leverage |
| Current ratio | 1.41adequate liquidity, worth monitoring |
| Beta | 1.09moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 464.92 - 710.97 |
| Moat | NARROW |
| Market cap | $38.4B |
| Employees | 9,600 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMLM trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Markup $543.77
+0.6% Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Markup $540.41
+0.0% Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Markup $540.41
+0.0% Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Markup · changed $540.41
+0.0% Entry 14
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $540.41
+6.6% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $507.17
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $507.17
+3.2% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $491.23
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation · changed $491.23
+0.0% Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689.
2026-10-18
Markdown $491.23
+0.1% Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (22 analysts) rates it buy, with a mean price target of $689.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- What Just Happened To Vulcan Stock? Yahoo Finance · 5d ago
- Is Martin Marietta Materials (MLM) Stock Reasonable At Current Levels? Yahoo Finance · 6d ago
- Vulcan Materials (VMC) Surpasses Q3 Earnings Estimates Yahoo Finance · 7d ago
- Analysts Estimate Martin Marietta (MLM) to Report a Decline in Earnings: What to Look Out for Yahoo Finance · 8d ago
- Can Martin Marietta Stock Jump 30%? Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
VMCVulcan Materials Company
CRHCRH plc
AMRZAmrize Ltd
CXCemex SAB de CV ADR
BZZUYBuzzi S.p.A.
USLMUnited States Lime & Minerals, Inc.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | LYONS MARTIN J JR | Director | 313 | · | |
| 2026-05-14 | PEREZ LAREE E | Director | 313 | · | |
| 2026-05-14 | SLAGER DONALD W | Director | 313 | · | |
| 2026-05-14 | DELLY GAYLA J | Director | 313 | · | |
| 2026-05-14 | WAJSGRAS DAVID C | Director | 313 | · | |
| 2026-05-14 | MACK MARY T. | Director | 313 | · | |
| 2026-05-14 | PIKE THOMAS | Director | 313 | · | |
| 2026-05-14 | ABLES DOROTHY M | Director | 313 | · | |
| 2026-05-14 | FOXX ANTHONY R | Director | 313 | · | |
| 2026-05-01 | SAMBORSKI CHRISTOPHER WILLIAM | Chief Operating Officer | 8,101 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $585.14 | -5.2% | $0.83 | $950 | -5.0% |
| 2 months | $630.63 | -12.0% | $0.83 | $881 | -11.9% |
| 3 months | $586.53 | -5.4% | $0.83 | $948 | -5.2% |
| 6 months | $630.40 | -12.0% | $1.66 | $883 | -11.7% |
| 1 year | $551.38 | +0.6% | $3.32 | $1,012 | +1.2% |
| 2 years | $546.18 | +1.6% | $6.48 | $1,028 | +2.8% |
| 3 years | $420.04 | +32.1% | $9.44 | $1,344 | +34.4% |
| 5 years | $342.03 | +62.3% | $14.52 | $1,665 | +66.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MLM does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.